FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q3 2025
Top Holdings144 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ISHR IBX USD HIYLD CB ETF-UI | 39M | $3.2B | 13.0% | — | — | — | Increased — |
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 3.4M | $2.3B | 9.3% | — | — | — | New — |
MICROSOFT CORP | 1.9M | $990.9M | 4.1% | $318.61 | +61.21% | 28 qtrssince 2018-Q4 | Increased 64 |
INVESCO S&P 500 EQUAL WEIGHT | 5.1M | $967.5M | 4.0% | — | — | — | Increased — |
AON PLC | 2.3M | $812.3M | 3.3% | $326.22 | +9.02% | 7 qtrssince 2024-Q1 | Increased 67 |
EXELIXIS INC | 19.5M | $805.4M | 3.3% | $22.96 | +76.72% | 28 qtrssince 2018-Q4 | Increased 70 |
AMAZON.COM INC | 3.5M | $769.7M | 3.2% | $223.15 | -0.44% | 2 qtrssince 2025-Q2 | Increased 67 |
NATERA INC | 4.3M | $684.7M | 2.8% | $74.46 | +119.04% | 18 qtrssince 2021-Q2 | Decreased 0 |
REVOLUTION MEDICINES INC | 14.6M | $683M | 2.8% | $35.04 | +31.48% | 19 qtrssince 2021-Q1 | Increased 55 |
UNITEDHEALTH GROUP INC | 1.9M | $651.4M | 2.7% | $440.57 | -22.18% | 11 qtrssince 2023-Q1 | Increased 63 |
THERMO FISHER SCIENTIFIC INC | 1.3M | $610.3M | 2.5% | $453.07 | +1.90% | 24 qtrssince 2019-Q4 | Decreased 0 |
HIMS & HERS HEALTH INC | 10.7M | $609.6M | 2.5% | $33.75 | +75.18% | 9 qtrssince 2023-Q3 | Increased 68 |
WALT DISNEY CO/THE | 5.2M | $595.3M | 2.4% | $97.49 | +16.94% | 6 qtrssince 2024-Q2 | Increased 58 |
SALESFORCE.COM INC | 2.5M | $583.6M | 2.4% | $232.51 | +5.25% | 24 qtrssince 2019-Q4 | Increased 63 |
AUTODESK INC | 1.7M | $528.2M | 2.2% | $294.73 | -18.01% | 4 qtrssince 2024-Q4 | Decreased 0 |
BOSTON SCIENTIFIC CORP | 4.7M | $463.4M | 1.9% | $61.24 | +58.46% | 21 qtrssince 2020-Q3 | Increased 58 |
ISHARES BITCOIN TRUST | 7M | $454.5M | 1.9% | $52.16 | +24.57% | 5 qtrssince 2024-Q3 | Decreased 0 |
WABTEC CORP | 2.2M | $442.1M | 1.8% | $135.99 | +45.12% | 28 qtrssince 2018-Q4 | Increased 73 |
BRIDGEBIO PHARMA INC | 8.2M | $425.5M | 1.7% | $33.40 | +55.53% | 5 qtrssince 2024-Q3 | Increased 51 |
PROTAGONIST THERAPEUTICS INC | 6.2M | $411.6M | 1.7% | $19.34 | +236.87% | 28 qtrssince 2018-Q4 | Increased 49 |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $24.4B across 144 positions as of Q3 2025. Top holdings: HYG (13.0%), SPY (9.3%), MSFT (4.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 21 new positions, 25 exits, 35 increased. Top move: WAB (INCREASED, conviction 73). Portfolio: $24.4B across 144 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer